AdaptHealth Corp. 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by AdaptHealth Corp. on January 4, 2021. The filing details the completion of a debt offering by AdaptHealth LLC, a wholly owned subsidiary, to finance the previously announced acquisition of AeroCare Holdings, Inc.
Key Financial Metrics and Debt Structure
- Debt Issuance: Completed offering of $500,000,000 aggregate principal amount of 4.625% Senior Notes due 2029.
- Use of Proceeds: Gross proceeds and accrued interest are held in escrow pending the AeroCare acquisition closing. Funds will finance the cash portion of the acquisition consideration and related fees.
- Debt Replacement: This offering replaces a bridge commitment previously received from Jefferies Finance LLC.
- Existing Debt: The new Notes rank equally with existing $350,000,000 of 6.125% senior notes due 2028 and are senior to future subordinated debt.
- Secured Debt: The Notes are effectively subordinated to secured debt, including a Credit Agreement providing for a $200 million revolving credit line and $250 million in term loans.
- Guarantees: Notes are guaranteed by AdaptHealth's subsidiaries (including AeroCare post-acquisition) and its direct parent, AdaptHealth Intermediate Holdco LLC.
Material Changes and Terms
The primary material change is the creation of a new direct financial obligation. The Notes mature on August 1, 2029, with interest payable semiannually beginning August 1, 2021. A special mandatory redemption clause exists if the AeroCare acquisition is not consummated by the "Merger Agreement Termination Date" (initially May 31, 2021, subject to extension), requiring repayment at 100% of the issue price plus accrued interest.
Redemption Provisions and Risks
- Voluntary Redemption: Notes are redeemable after February 1, 2024, at declining premiums (102.313% in 2024, 101.156% in 2025, 100% thereafter). Pre-2024 redemption is possible at a "make-whole" premium or up to 40% using equity proceeds at 104.625%.
- Change of Control: AdaptHealth may be required to make an offer to purchase the Notes upon specific changes of control or asset sales.
- Liquidity Risk: Proceeds are currently restricted in escrow and contingent upon the successful closing of the AeroCare merger.
Investor Verification Checklist
- Verify the status of the AeroCare Holdings, Inc. acquisition and the expected closing date.
- Confirm the "Merger Agreement Termination Date" to assess the risk of special mandatory redemption.
- Review the full Indenture (Exhibit 4.1) for detailed covenants and guarantee structures.
- Monitor the company's ability to service the new $500 million debt alongside existing $350 million senior notes and secured credit facilities.